Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation"

Abroad (travel likely)RecruitingPHASE3

Conditions

Alpha 1-Antitrypsin Deficiency

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University Hospital (UZ) Leuven, Leuven, Belgium
Contact: Study coordinator (Wim Janssens) · wim.janssens@uzleuven.be · 003216340957
Tays Central Hospital, Tampere, Finland
Contact: Study coordinator (Joni Niskanen) · joni.niskanen@pirha.fi · 00358 3 3116 3130
Contact: Study coordinator (Minttu Kopra) · minttu.kopra@pirha.fi · 00358444722863
Beaumont Hospital, Dublin, Ireland
Contact: Study coordinator (Gerry McElvaney) · gmcelvaney@rcsi.ie · 0035318093763
Leiden University Medical Center (LUMC), Leiden, ZA, Netherlands
Contact: Study coordinator (Prof. Jan Stolk, MD PhD) · research-longziekten@lumc.nl · 0031 71 526 2950
Study coordinator · research-longziekten@lumc.nl
Canisius Wilhelmina Hospital (CWZ), Nijmegen, Netherlands
Contact: Study coordinator (Rob Janssen) · res.long@cwz.nl · 0031243658755
Study coordinator · res.long@cwz.nl · 0031243657944
Skåne University Hospital, Malmö, Sweden
Contact: Study coordinator (Hanan Tanash) · hanan.tanash@med.lu.se · 0046040332180
Contact: Study coordinator (Louise Qvist) · louise.qvist@med.lu.se · 0046040337574
University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
Contact: Study coordinator (Alice Turner) · alice.turner2@uhb.nhs.uk · 00441213713886
Contact: Study coordinator (Anita Pye) · Anita.Pye@uhb.nhs.uk · 00441213713886
Royal Infirmary of Edinburgh, Edinburgh, United Kingdom
Contact: Study coordinator (Gourab Choudhury) · Gourab.choudhury@nhs.scot · 00441312422064
Contact: Study coordinator (Eleni Koullia) · eleni.koullia@nhs.scot
University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
Contact: Study coordinator (Aishath Fazleen) · aishath.fazleen@uhs.nhs.uk · 00442381206397
Contact: Study coordinator (Ruben Magalhaes) · aatdservice@uhs.nhs.uk · 004423 8120 4479

Study leads

Jan Stolk, Prof
Principal Investigator
LUMC

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)

Alpha 1-Antitrypsin Deficiency

Abroad (travel likely)RecruitingPHASE1, PHASE2

Birmingham, United States · Boston, United States

PiMZ Longitudinal Cohort (PiMZ Logic)

Alpha 1-Antitrypsin Deficiency · Emphysema or COPD

Abroad (travel likely)Recruiting

Birmingham, United States · Los Angeles, United States

Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency

Alpha 1-Antitrypsin · COPD · Antibody Deficiency

Abroad (travel likely)RecruitingPHASE4

Birmingham, United States

Screening for Alpha-1 Antitrypsin Deficiency in Patients With Airway Obstruction

Alpha 1-antitrypsin Deficiency (AATD)

Abroad (travel likely)Recruiting

Muğla, Turkey (Türkiye)